Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

High-flow nasal oxygen versus face mask oxygen for sedated gastroscopy in people with visceral obesity

Official title: High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy: A Randomized Controlled Trial.

Run by Shanghai Zhongshan Hospital · NCT07159022 · Data updated 2026-11-12

This test sees if using high-flow nasal oxygen instead of a standard face mask keeps oxygen levels better during sedated gastroscopy for people with visceral obesity.

More High-flow Nasal Cannula trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment200 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedAugust 31, 2025
Main results expectedJune 30, 2026
Study endsJuly 31, 2026
Registry record updatedDecember 1, 2025
Trial IDNCT07159022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with visceral obesity (BMI ≥28 and BRI ≥5.46), ASA class I–III, who are scheduled for sedated gastroscopy are the ideal candidates.

Probably not a fit

People without visceral obesity or those with contraindications such as recent thoracic surgery, nasal/nasopharyngeal disease, tracheostomy, severe unstable heart or pulmonary conditions, bleeding disorders, or pregnancy are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an unblinded randomized controlled comparison of high-flow nasal cannula (HFNC) oxygenation versus standard face mask oxygenation in patients with visceral obesity undergoing sedated gastroscopy. Eligible adults have BMI ≥28 and a body roundness index (BRI) ≥5.46 and are ASA class I–III. Patients are randomly assigned to receive HFNC or mask oxygen during the procedure and monitored for oxygenation, hypoxemic events, and related airway complications. The trial is being conducted at Zhongshan Hospital in Shanghai and focuses on intra-procedural respiratory outcomes.

Why it matters

Potential benefit: If successful, HFNC could reduce episodes of low oxygen and improve safety during sedated gastroscopy in people with visceral obesity.

How similar studies have gone: Some prior small studies and clinical experience suggest HFNC can improve oxygenation during sedated endoscopy in obese patients, but high-quality evidence remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA class ≤Ⅲ
* Visceral obesity(body mass index≥28 and BRI ≥5.46)
* Patients who will undergo sedated gastroscopy

Exclusion Criteria:

* Life-threatening heart disease or acute myocardial infarction within 6 weeks
* Presence of pneumothorax or pulmonary bullae, pulmonary embolism, pulmonary oedema
* Upper respiratory tract infection
* Presence of tracheostomy
* Nasal or nasopharyngeal diseases
* Coagulation disorders or a tendency of nose bleeding
* Pregnancy
* Recent (within 1 week) thoracic surgery
* Emergent procedure or surgery
* Allergy to drugs used during the procedure
* Unwillingness to participate in the study

Where it's running

  • Zhongshan Hospitla
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.